Glucocorticoid Receptor (GR, or GCR) also known as NR3C1 (nuclear receptor subfamily 3, group C, member 1) is the receptor to which cortisol and other glucocorticoids bind. The GR is expressed in almost every cell in the body and regulates genes controlling the development, metabolism, and immune response. When the glucocorticoid receptor binds to glucocorticoids, its primary mechanism of action is the regulation of gene transcription. The unbound receptor resides in the cytosol of the cell. After the receptor is bound to glucocorticoid, the receptor-glucorticoid complex can take either of two paths. The activated GR complex up-regulates the expression of anti-inflammatory proteins in the nucleus or represses the expression of pro-inflammatory proteins in the cytosol by preventing the translocation of other transcription factors from the cytosol into the nucleus. Dexamethasone is an agonist, and RU486 and cyproterone acetate are antagonists of the GR. Also, progesterone and DHEA have antagonist effects on the GR.
AZD2906
Cat. No.: HY-113854 AZD2906 is a selective glucocorticoid receptor agonist, increases micronucleated immature (GR) erythrocytes in the bone marrow of rats. AZD2906 shows s of 2.2, 0.3, 41.6 and 7.5 nM at GR in IC 50 human, rat PBMC and human, rat whole blood, respectively.
Purity:
99.82% Clinical Data: No Development Reported Size:
10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
AZD5423
Cat. No.: HY-108243 AZD5423 is an inhaled, potent, selective, and non-steroidal glucocorticoid receptor (GR) modulator (SGRM). AZD5423 effectively reduces allergen-induced responses in subjects with mild allergic asthma. 
Purity

